OssDsign
10,04
SEK
+0,9 %
OSSD
First North Stockholm
Biotechnology & Pharmaceuticals
Health Care
4 investorer følger denne virksomhed
+0,9%
+24,72%
+47,21%
+8,07%
+25,5%
+32,11%
+16,74%
-22,29%
-42,23%
OssDsign operates in the pharmaceutical industry. The company is specialized in the research and development of pharmaceuticals for bone defects. The pharmaceuticals are based on bioceramic material whose composition is used to improve the healing process in various cases of patient injuries. The products are resold as implants and are mainly used for the treatment of head injuries.
Læs mereMarkedsværdi
980,5 mio. SEK
Aktieomsætning
3,86 mio. SEK
Omsætning
112,16 mio.
EBIT %
-81,99 %
P/E
-
Udbytteafkast, %
-
Finanskalender
4.2
2025
Årsrapport '24
ViserAlle indholdstyper
Notice to attend the extraordinary general meeting in OssDsign AB
Redeye: OssDsign Q3 - Better than expected
Join Inderes community
Don't miss out - create an account and get all the possible benefits
Inderes account
Followings and notifications on followed companies
Analyst comments and recommendations
Stock comparison tool & other popular tools